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Background: The estimated prevalence of irritable bowel syndrome (IBS) is 10%. Up to one third of patients
develop chronic symptoms, which impact on everyday functioning and psychological wellbeing. Guidelines suggest
an increased role for primary care in the management of patients with IBS, and referral for psychological
interventions. Literature reports dissatisfaction and frustration experienced by both patients with IBS and healthcare
professionals. The aim of this study was to explore the perspectives of general practitioners (GPs) in relation to the
diagnosis and management of IBS and their views on the potential use of a risk assessment tool to aid
management decisions for patients with IBS in primary care.
Methods: This was a qualitative study using face-to-face semi-structured interviews with GPs in North West
England. Interviews were fully transcribed and data analyzed using constant comparison across interviews. Tensions
between GP accounts and the NICE guideline for the management of IBS were highlighted.
Results: GPs described IBS as a diagnosis of exclusion and the process as tentative and iterative, with delay in
adding a Read code to the patient record until they were confident of the diagnosis. Whilst GPs accepted there
was a link between IBS and psychological symptoms they suggested that the majority of patients could be
managed within primary care without referral for psychological interventions, in conflict with the NICE guideline.
They did not feel that a risk assessment tool for patients with IBS would be helpful.
Conclusions: This study highlights the tensions between evidence recognizing the need to identify patients whose
symptoms may become chronic and offer pro-active care, including referral for psychological therapies, and the
perspectives of GPs managing patients in every-day clinical practice. The reluctance of GPs to refer patients for
evidence-based psychological treatments may have implications for commissioning services and patient care.
Keywords: Irritable Bowel Syndrome, Functional Gastrointestinal Disorders, Medically Unexplained Symptoms, NICE
Guideline, Primary Care, General PractitionersBackground
Irritable bowel syndrome (IBS) is the commonest of the
functional gastrointestinal disorders [1], with an esti-
mated prevalence of 10% [2]. It is a chronic, relap-
sing and often life-long disorder, characterized by the
presence of abdominal pain/discomfort associated with
defaecation, a change in bowel habit, the sensation of* Correspondence: Elaine.F.Harkness@manchester.ac.uk
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colonic symptoms. As with other ‘medically unexplained
symptoms’ (MUS) people with persistent symptoms of
IBS have poor physical function, impaired quality of life
and high healthcare costs [3]. There is evidence of im-
pairment of health-related quality of life (QOL) [4,5] and
qualitative studies have highlighted how symptoms im-
pact on daily functioning, personal and social relation-
ships, self-image and psychological well-being [6,7]. The
main predictors for chronicity are psychological distress,
symptom duration and disruption of social activities [8].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and severity of symptoms at baseline [9,10].
The majority of patients with IBS are managed within
primary care [11] and of those who consult their GP, it has
been estimated that up to a third will go on to develop
chronic symptoms [8]. The NICE (National Institute for
Health and Care Excellence) guideline (CG61 2008) [12]
emphasizes establishing a positive diagnosis, identifying
symptoms that require prompt referral, but avoiding un-
necessary investigations and referrals and working in part-
nership with the person with IBS. The guideline outlines
the evidence for the effectiveness of psychotherapy, cog-
nitive behavioural therapy (CBT) and hypnotherapy in
those patients whose symptoms do not respond to
pharmacological treatments after 12 months; and em-
phasizes that the partnership between patient and GP
is key, using shared decision-making to aid symptom
control [12].
Patients with IBS disproportionately use primary and
secondary care services, with sufferers consulting GPs
more frequently than matched controls [4,13]. There is
evidence of dissatisfaction and frustration voiced by pa-
tients and doctors alike. This arises from uncertainties in
aetiology and the contested nature of the diagnosis [14],
ineffective treatments and a mismatch between GP and
patient explanatory models [7,15]. In turn, this can lead
to negative stereotyping of patients with IBS by doctors
[7,14] and for patients, it may lead to a breakdown in
trust and disengagement from services [6,16].
Bijkerk et al. (2003) report that patients and GPs share
similar views on aetiology and symptomology, but differ
in treatment approaches found acceptable [17]. Dixon-
Woods and Critchley (2000) report that GPs can hold
hostile views about patients with IBS who are frequent
attenders and do not improve [14]. There is little previ-
ous work on how a diagnosis of IBS is made in primary
care and how this label is applied. Yale et al. (2008)
reported that only a small proportion of IBS cases, as
recorded in medical records, met case definition cri-
teria, suggesting that diagnosis in primary care may be
problematic [18].
This qualitative study was nested in an NIHR (National
Institute for Health Research) programme of work
(RP-PG-0407-10136) in which one aim was to validate
prospectively a risk assessment tool which was developed
following an investigation of the predictors of persistent
gastrointestinal symptoms amongst new presenters to pri-
mary care [8]. The aim of the tool is to identify which
patients presenting with a new episode of IBS will go on
to develop persistent symptoms, and may therefore
potentially benefit from referral for more intensive
management, including psychological therapies. The
participating practices were not expected to use the
tool, but recruit patients to the study.The aim of the study presented here was to explore
qualitatively how GPs currently diagnose and manage
IBS, whether management described is consistent with
the NICE guideline [12], and GP attitudes towards a pre-
dictive, risk assessment tool to aid management and re-
ferral decisions in primary care.
Methods
Design
Face-to-face, in-depth, semi-structured interviews were
conducted with GPs in Greater Manchester, England
who were participating in a larger programme of work
which aimed to validate prospectively a risk assessment
tool for predicting chronicity in patients with IBS. Initially
we approached all practices that had a Service Level
Agreement with the Greater Manchester Comprehensive
Local Research Network (CLRN). We then took a staged
approach to roll the study out to general practices within
Primary Care Organisations in Greater Manchester. The
total number of practices recruited to the study was 58. At
the time of recruitment practices were informed about
both the Risk Assessment Study and the qualitative inter-
view study. GPs were invited to contact us if they were in-
terested in taking part in the qualitative study. The role of
the practices was to recruit patients to the study, rather
than use the predictive tool. Data were collected between
March and December 2011.
Sampling
Purposive sampling was used to maximise the variation
of the sample of GPs. GPs who were invited to partici-
pate in the main study were also invited to participate in
this nested qualitative study and two GPs agreed. The
remaining 17 GPs were recruited from the 58 practices
who had agreed to recruit patients for the main study.
We sampled practices according to location, and asked
if one of the GPs would participate in the interview
study. As recruitment continued, we tried to ensure a
spread of participants across gender, ethnicities, age
ranges and years of experience in practice. Recruitment
was then continued until theme saturation was achieved.
Data collection
Interviews were conducted, with written consent, at
GPs’ premises, by two of the authors (EFH and VH).
Interviews lasted between 20 and 70 minutes (mean 42
minutes). The topic guide was developed from review of
the existing literature and discussion within the research
team. The topic guide, designed to be used flexibly, was
modified in the light of emerging themes. The main
areas explored were GPs’ views on the aetiology of IBS,
how they make the diagnosis of IBS and explain this to
patients, treatments offered to patients, and the potential
usefulness of a tool to aid their management decisions.
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management device to help stratify patients into those
who might become high consulters in the long term,
and thus may aid future decisions about management of
these patients.
Interviews were fully transcribed. Data coding was by
constant comparison across interviews [19], by individ-
ual authors (CCG, EFH, VH and SH) and emerging
themes were agreed through discussion amongst all
authors, from different professional backgrounds (aca-
demic primary care, health services research, epidemi-
ology). An iterative approach to data collection and
analysis was taken; coding and conceptual categories
were constantly reviewed and refined in the light of new
interview data and ongoing discussion in the research
team. Tensions between GP descriptions of their man-
agement and the NICE guideline were particularly inves-
tigated in the analysis. The topic guide was modified to
allow for further exploration of emerging themes. N
Vivo 9 (QSR International Pty Ltd, Victoria, Australia)
was used to store and manage the data.Results
Nineteen interviews with GPs were conducted (see
Table 1); 17 GPs had agreed that their practice would
recruit patients for the larger programme, two GPs had
agreed to be interviewed but their practices declined to
recruit patients for the main study. The following
themes are presented: an accepted illness, categorizing
the patient, diagnosing and labeling, approaches to
management, and the utility of a predictive tool in
decision-making. Data are presented verbatim from
transcripts and identified by a code attributed to the




Age group 30-39 7
40-49 5
50+ 7
Ethnic origin White 13
Asian/ Asian British 5
Black/ Black British 1
Status Principal 17
Salaried 2
Mean (range) years in practice 15.4 (4 to 28)
Type of practice Inner City 2
Urban 9
Suburban 8An accepted illness
All GPs recognized the existence of IBS and suggested
that the diagnosis is not contentious:
‘I do think it exists, I really do. I think people's lives
can be made - it's a label isn't? People who have got
constipation predominant IBS might - you could just
call them constipated. It's a real condition, people get
a lot of pain from it. There are people that seem to get
more anxious about it. But we all get a dodgy tummy
if you've got an exam or something like that. So I
definitely think it exists.’ GP11
All GPs described IBS, however, as a complex condi-
tion with a biopsychosocial aetiology, with patients pre-
senting symptoms related to ‘stress’ and lifestyle which
could be difficult to untangle:
‘I think there's a lot of psychology with irritable
bowel, not that necessarily the psychology causes the
irritable bowel but I think for a fairly benign
condition it can cause a lot more upset than you'd
expect.’ GP9
GPs suggested that most patients are ready to accept the
link between psychosocial issues and bowel symptoms,
and may even have considered this before consulting:
‘Whereas if I involve them throughout the process right
from the beginning, er, they adhere to it. I haven't had
a single problem with bringing up psychological issues
with any of my patients, yeah.’ GP13
Some GPs alluded to their own experiences, which
made symptoms in patients more real, understandable
and perhaps a more acceptable diagnosis to make:
‘I think I’ve dealt with it so much, I’ve experienced
it as well and so I think when you’ve experienced it
you know how severe some of the symptoms can be.’
GP11
Categorizing the patient
Most GPs recognised the chronicity of IBS and some
suggested that there were a minority of patients who did
not improve, attended frequently and were difficult to
manage:
‘I suspect to patients it's a complete nightmare cos
it's the daily thing of living with it, but in general, I
have to say my experience is that we can help
patients but, you know, to improve their quality of
life enormously is not necessarily that easy with
irritable bowel.’ GP9
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offer to patients with IBS:
‘It’s only really if it’s…if there’s no obvious trigger
and if it’s causing significant impact on their life.
That’s when it becomes very challenging because I
think it’s relatively limited what you can do.’ GP6
GPs recognized that other patients do not return and
attributed this to patients either being satisfied with the
management offered, or that they simply ‘put up with’
their symptoms:
‘But sometimes they just never come back and
then you just assume they've got better [laughter].’
GP14
‘Whether it’s that they just manage it or whether it’s
just that we don’t ask them about it any more and
they just put up with it I don’t know.’ GP8
It was thought that only a minority of patients would
become frequent attenders:
‘I mean there are, I guess a sub group of patients
with IBS who are the real sort of somatisers I guess,
the real patients that, erm, could be termed doctors
heart sink patients, erm, so patients that, that are
generally very anxious but are anxious about their
health, they’re anxious about every little symptom.
There is a small group of patients with IBS who fit
into that group and so that group of patients have
certain patterns, but I wouldn’t say that all patients
with IBS are like that.’ GP18
Diagnosing and labeling
GPs suggested that the first step in making the diagnosis
and managing people with IBS is ensuring that the pa-
tient’s concerns are listened to:
‘…it helps just to reassure the patient that you’re
taking the symptoms seriously. I think that’s
probably the biggest worry they have, because when
you have some functional symptom and you’ve
nothing to show the doctor, it’s almost inevitable
that you’re going to wonder whether he’ll take it
seriously…’ GP3
Most GPs were aware of the NICE guideline [12] for
IBS but only a minority of GPs suggested using the
guideline [12] to assist them in managing a patient:
‘I am aware of them, yeah I am aware of them, the
problem with the NICE guidelines is there's millionsof them and it's absolutely impossible in normal
general day to day practice to be au fait with them
all. I would look at them if I really was struggling
with managing a patient’. GP9
The NICE guideline suggests that the diagnosis of IBS
should be made in a positive manner considering the
symptoms which pointed towards the diagnosis: many
GPs felt uncomfortable with this approach, and although
few described referring to secondary care to obtain a
diagnosis unless there were clear ‘red flag’ symptoms,
they described IBS as a diagnosis of exclusion, and the
diagnostic process as tentative and iterative, by exclusion
of sinister symptoms, the approach taught at medical
school:
‘So to a certain extent there’s always a degree of
diagnostic uncertainty because… although I know the
term isn’t really favoured any more, but pretty much
it’s a diagnosis of exclusion.’ GP18
‘So now it’s very difficult, yeah, I read the NICE
guidelines and it is about positive, it’s not a diagnosis
of exclusion any more, it’s about positive symptoms.
I’ve read all that but it’s still very hard to go away
from something that was drummed in.’ GP11
Making a diagnosis based on the patient response to
medication was also described:
‘…and, you know, their full blood count would be
alright, their coeliac screen would be negative, erm…
and then we'd…you know, I'd often give them a trial
of Mebeverine or something and that quite often
does help, and then they just stay on that.’ GP14
GPs reported that they did not initially add a Read
code for IBS to the patient record, but delayed until they
were more confident in the diagnosis. Thus, codes such
as ‘abdominal pain’, ‘diarrhoea’ or ‘constipation’ would re-
main on the patient record, rather than IBS, and patients
who do not return with their gastrointestinal symptoms
would not be coded as having IBS:
‘I’d probably put a symptom as the coding on the
computer at that stage; the most predominant
symptom, but if the patient has come in with the
same sorts of things over and over again and it’s
looking very much like IBS, and it responds to IBS
type treatment, then I’d code it.’ GP1
Approaches to management: NICE-compliant?
All GPs suggested that giving lifestyle advice, predomin-
antly about diet, to help the patient self-manage their
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most conceded that patients had already tried to modify
their diet before consulting:
‘Some patients have already identified it – ‘My
problems seem far worse when I eat such and such…’
so then we say hang on, why don’t you just not eat
such and such and see how you do and if they feel
that their symptoms have been looked into adequately
enough, and they’re reassured that it’s IBS then they’re
happy to do that.’ GP18
Some GPs suggested that a focus on the related psy-
chological symptoms within early consultations might
lead to improvement in gastrointestinal symptoms:
‘Then I tend to sort of not label them as IBS
straightaway, yeah. I will manage the stress, I will
manage their anxiety, I'll manage the depression and
see what happens with the symptoms.’ GP13
Despite acknowledging the link between psychological
symptoms and IBS, all GPs were reluctant to refer pa-
tients with IBS for psychological therapies, which is
against the recommendation in the NICE guideline [12].
GPs described such primary care mental health services
as scarce resources with long waiting times, so they felt
the need to reserve these interventions for those patients
who they felt had more overt mental health symptoms,
rather than a condition such as IBS:
‘We can refer to the Mental Health team for the
depression, with the hope that it might help the IBS
symptoms at the same time. We couldn't refer
primarily for the IBS.’ GP12
Although psychological therapies such as CBT and
hypnotherapy are recommended interventions for IBS
in the NICE guideline [12] some GPs expressed doubt
about the evidence-base for these interventions:
‘…the NHS does need to be careful about where it
puts its money because…, perhaps we ought to be
putting the money into more evidenced based
things.’ GP12
‘I need to be sort of…I’m not quite sure of the link
between why CBT might work, the connection between
the psychological component and the patient’s IBS,
and CBT. I’m assuming there are studies to show that
it does work?’ GP2
GPs recognized that many patients sought help from
complementary therapists and either encouraged this orat least did not discourage this approach, which is not
advocated by the NICE guideline:
‘…what I would call a functional bowel disorder and
helping manage triggers, a bit, in terms of diet and
lifestyle and looking at stress and if they…you know, if
they’re doing that and they want to do a bit of
homeopathy, as well, okay.’ GP19
One GP described delivering acupuncture to patients
with IBS:
‘Again it’s a balance between getting… being swamped
with IBS patients…I told you about a patient who I
knew as a friend who, erm, had IBS and he had
leakage and when he used to go running, he was very
fit, you know, and he used to soil himself I suppose
and he tried all medication and I acupunctured him
and it stopped him overnight.’ GP16
Utility of a predictive tool in management and referral
Despite some recognition that there might be a group of
patients who may become frequent attenders, GPs did
not feel that a risk assessment tool to predict which pa-
tients might become high users of care, and thus might
benefit from early intervention, would have any utility
particularly given the perceived lack of availability of any
treatments or referral options:
‘But don’t we intervene anyway? It’s not as if we sit
there doing nothing unless we think someone’s going to
be a high consulter, so what actual outcome is that
going to have to me and my practice?’ GP6
Other GPs expressed concern about the practicalities
of administering such a tool in a time-limited primary
care consultation:
‘…I can't be doing with having piles of bits of paper,
every speciality has got dozens of bits of paper like this
and we work across every single speciality, so having
bits of paper in the room is a complete loss.’ GP4
‘…they’re a pain though, using questionnaires in
consultations because you have to find it, you have to
print it off if you’ve got it on your computer, if you give
it to your patient they then…you can send them away
to fill it in but if they fill it in there and that’s in a ten
minute consultation.’ GP11
So the value of a tool to predict which patients might
benefit from early intervention for their abdominal symp-
toms, and direct management decisions, was perceived to
be limited to GPs.
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Summary of main findings
This study illustrates how the perspectives of GPs about
the diagnosis and management of IBS influence their
views on the value of psychological interventions and a
risk assessment tool to predict chronicity. GPs accepted
that IBS was a legitimate diagnosis to make, although all
described reverting to past learning and making the
diagnosis by exclusion of sinister symptoms, rather than
working with the patient’s positive symptoms suggestive
of IBS. In addition, they described reluctance to add the
Read code for IBS to a patient’s record, and reflected
that many patients with symptoms suggestive of IBS
would never receive this label. GPs suggested that most
patients with IBS were not difficult to manage; they ac-
knowledged the link between IBS and psychological dis-
tress but were reluctant to refer for therapies such as
CBT or hypnotherapy, which are advocated by the NICE
guideline [12], and did not see the value of a risk assess-
ment tool to predict chronicity and to define who may
benefit from such psychological interventions. Most GPs
suggested that patients did not return because their
symptoms had settled, rather than because they may be
dissatisfied with care.
Strength and limitations of the study
Data are presented from interviews with GPs over a wide
geographical area; this purposive sampling enabled us to
access a range of views. However, because we employed
a theoretical sampling approach, the proportion of GPs
holding different views cannot be inferred. Seventeen
out of the 19 GPs interviewed were recruiting patients
to a study attempting to evaluate the usefulness of a risk
assessment tool for IBS in primary care, and were pos-
sibly more likely to feel comfortable managing IBS in
primary care. These GPs were not using the predictive
tool themselves. Furthermore, the proportion of GPs
with patients who suffered prolonged or severe forms of
IBS is likely to be limited, and in these instances GPs
may be more likely to seek external help to support
management.
The two GPs who agreed to be interviewed but not to
participate in the main study might have been expected
to have more negative views about IBS, however this
was not apparent in the data.
GPs understanding of the Risk Assessment Tool may
have been limited, this was often introduced towards the
end of the interview and the way it was presented to re-
spondents could have been different, for example the
use of vignettes may have led to a better understanding
and discussion of the aims of the risk assessment tool.
Data were collected and analyzed by researchers from
different professional backgrounds, thus increasing trust-
worthiness of the analysis [20].Comparison with existing literature
The diagnosis of MUS is often contentious [21], however
GPs in this study accepted the existence of IBS, and
reported that they had no difficulty in making the diagno-
sis, or in the management of patients with IBS. These find-
ings are similar to those of Thompson et al. (1997) who
reported that compared with pelvic and back pain, IBS
was not considered difficult in terms of distinguishing
functional from organic disease [22]. When GPs experi-
enced IBS themselves, or knew someone with IBS, it
helped them to understand the condition, resonating with
Chew-Graham et al. (2008) who described a similar find-
ing with GPs who had first-hand experience of Chronic
Fatigue Syndrome [23].
Respondents recognized the link between IBS and psy-
chological distress [11,17,22,24], though they were uncer-
tain of the benefit of psychological therapies in patients
with IBS, despite recent evidence of their effectiveness
[25,26]. It has previously been reported that GPs in the
UK do not refer patients with IBS for psychological treat-
ment [15,22], whereas doctors in the Netherlands are
more likely to do so [15]. This is in direct contradiction to
the NICE guideline [12] which recommends referral for
patients for psychological treatments if symptoms have
been present for 12 months or are refractory to treatment.
The NICE guideline [12] recommends annual review of
patients with IBS, but no GPs reported offering this. In
addition, the guideline suggests that patients should be
discouraged from seeking complementary therapies
such as acupuncture and reflexology. Some GPs in this
study reported giving the message that such therapies
could be helpful, with one GP delivering acupuncture to
selected patients with IBS, in contradiction to the NICE
guideline [12].
Previous literature suggests that the diagnosis of IBS is
made by excluding red flag indictors, and our study sup-
ports this. Hungin et al. (2003) reported that 19% of pa-
tients formally diagnosed with IBS had been given the
diagnosis on their first visit, and 56% after a further 1–5
visits [27]. This contrasts with a study in which 72% of
GPs considered that they were usually or often able to
diagnose IBS at the initial visit [22]. These studies were
conducted prior to the introduction of the NICE guideline
for the diagnosis and management of IBS [12]. However,
although most GPs in our study were aware of the guide-
line, which recommends making a positive diagnosis con-
sidering the presence of symptoms, most described an
iterative approach to diagnosis with emphasis on exclusion
of ‘red flag’ symptoms and described concern about miss-
ing something more serious. Thus GPs were reluctant to
apply a label of IBS to patients and Read codes were
reported as only being applied if the patient re-consults
(which they often do not, [6,16]) perhaps explaining differ-
ences in prevalence rates of IBS in the literature [27,28],
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dition [29]. This approach has implications for the man-
agement of other MUS, particularly those which are less
acceptable, for example Chronic Pelvic Pain (CPP) [21],
and for GP training about these conditions.
GPs emphasized the importance of self-management
in patients with IBS, and felt that offering advice and re-
assurance was important in the first instance. Dietary
advice was emphasized by our respondents, but Bijkerk
et al. (2003) reported that dietary advice was not appre-
ciated by patients, who were likely to have already tried
such measures before consulting [17].
A strong physician-patient relationship and empowering
explanations given by GPs are reported to be important to
the successful management of IBS [1,30]. However,
Casiday et al. (2008) found that GPs often gave the prob-
lem back to the patient [15]. Dixon-Woods et al. (2000)
reported that healthcare professionals tended to distin-
guish between ‘good’ and ‘bad’ patients; with so-called
‘bad’ patients being unaccepting of the diagnosis of IBS,
recurrent attenders, demanding of further investigations,
failing to cope or respond to treatment, and resentful of
the IBS label and psychological explanations given [14].
‘Good patients’, on the other hand, were those who GPs
suggested had a sense of relief with the label given and
were accepting of the diagnosis [14]. In the current study,
GPs suggested that most patients did not return, attribut-
ing this to patients either getting better or learning to live
with their symptoms. However, there is evidence to sug-
gest that patients with IBS disengage from services be-
cause of dissatisfaction with GP interactions [16], a
belief that there is little the NHS can offer, or attribut-
ing the onset or worsening of symptoms to previous
poor medical care [6].
Of those who consult their GP with a functional gastro-
intestinal disorder approximately 30% go on to develop
chronic symptoms [8]. Robinson et al. (2006) demon-
strated that provision of a self-help guidebook, designed
with the aid of patients, reduced primary care consulta-
tions by 60% [31]. In addition, for patients with in-
tractable symptoms resistant to conventional medical
therapy, there may be therapeutic benefit from CBT or
hypnotherapy [25,26]. Thus, a risk assessment tool may
aid GP decisions about the management of patients at
risk of poorer outcomes and fast-track them to therap-
ies that are known to be effective, such as CBT or
hypnotherapy, leading to lower levels of distress and
healthcare utilization in the long term. Despite most
GPs agreeing to recruit patients to the validation study
of the risk assessment tool, the majority of GPs
interviewed did not feel that a risk assessment tool
would be useful to them, whilst others felt that the ad-
ministration of such a tool would be impractical in a
ten-minute consultation.Conclusions
Parallels can be drawn with the use of the PhQ-9 where
GPs are less receptive of a tool than patients [32], and
the value of a tool based on prognostic information to
determine the appropriate intervention for patients with
back pain that has been shown to be effective [33,34].
Despite the lack of enthusiasm for a risk assessment tool
for IBS by GPs, patients might be appreciative of such a
tool within the consultation; it may show that the doctor
is taking their symptoms seriously and demonstrate pa-
tient involvement in decision-making about treatment.
This would need to be explored further.
Although the NICE guideline [12] clearly recommends
the use of psychological interventions such as CBT and
hypnotherapy, for people with chronic symptoms of IBS,
the reluctance of GPs to refer patients for such therapies
may mean that clinical commissioning groups, led by
GPs, are unlikely to commission psychological services for
people with IBS, and patients do not receive effective care.
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